Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!

William W. Busse
  • European Respiratory Journal, May 2018, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.00730-2018
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
Read Publication

http://dx.doi.org/10.1183/13993003.00730-2018

In partnership with: